The FDA has received 65,969 adverse event reports for dogs that name Afoxolaner.
- 65,969 reports name Afoxolaner in dogs, which is 6.6% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 31% are marked serious and 3.1% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 37% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, diarrhoea and lethargy.
- The FDA lists 2 approved animal drug applications containing Afoxolaner for dogs, the earliest approved in 2013.
- None of this is a rate. The FDA data does not record how many dogs were given Afoxolaner, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 20,476 | 31% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 2,032 | 3.1% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 24,177 | 37% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 4,766 | 7.2% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 6,426 | 9.7% | 21% |
Where on the body do the reported signs sit?
Not on the body: Did not work 33% Whole body 9.3%
- Stomach and gut33%vomiting, diarrhoea, not eating, anorexia
- Did not work33%lack of efficacy (ectoparasite) - tick, lack of efficacy (ectoparasite) - flea, lack of efficacy (bacteria) - borrelia, lack of efficacy (tick) and 5 more
- Skin and coat11%skin disorders, pruritus, itching, scratching
- Whole body9.3%lethargy, lethargy
- Brain and nerves8.9%seizure, shaking, ataxia
- Heart and breathing2.0%panting
- Behaviour1.9%behavioural disorder
- Blood and organ tests1.5%other abnormal test result
Each figure is a share of sign mentions among the 25 signs reported most for Afoxolaner in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting16,236 25%
- Diarrhoea6,252 9.5%
- Lethargy5,703 8.6%
- Lack of efficacy (ectoparasite) - tick5,196 7.9%
- Lack of efficacy (ectoparasite) - flea4,628 7.0%
- Seizure4,511 6.8%
- Lack of efficacy (bacteria) - Borrelia3,843 5.8%
- Lack of efficacy (tick)3,389 5.1%
Reports received per year
Is it approved for dogs?
The FDA lists 2 approved animal drug applications containing Afoxolaner for dogs, the earliest approved in 2013.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Afoxolaner in cats (86 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Fluralaner in dogs68,773
- Sarolaner in dogs70,962
- Praziquantel in dogs59,564
- Moxidectin in dogs76,891
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.